Infectious Diseases II

428 flashcardsby Cory
Study these flashcardsFree · spaced repetition · iPhone, Android, Mac & web

First 300 of 428 cards

1
Which structures are involved in a superficial incisional SSI?
skin or subcutaneous tissue of the incision
2
Which structures are involved in a deep incisional SSI?
fascia and/or muscular layers
3
What does an organ or space SSI involve?
any space or organ, opened or manipulated during the procedure
4
What is the main source of organisms causing SSIs?
the microbiome of the patient’s skin or nares
5
Which organisms are among the most common SSI pathogens?
S aureus, coagulase-negative staphylococci, Streptococci spp, Enterococcus spp, and E coli
6
What preoperative glucose goal is listed for patients with diabetes?
110-150 mg/dL
7
When should prophylactic antibiotics generally be administered before surgery?
within 1 hour before surgery
8
When should vancomycin or fluoroquinolone prophylaxis be administered?
within 2 hours before surgery
9
What cephalosporin is described as having very low cross-reactivity with penicillin?
cefazolin
10
What is the preoperative S. aureus nasal decolonization regimen?
mupirocin 2% ointment twice daily for up to 5 days before surgery
11
What is the recommended antiseptic for surgical skin preparation?
Alcohol-based antiseptic solutions with chlorhexidine gluconate
12
What combination is recommended for colorectal bowel preparation?
oral antibiotic prophylaxis and mechanical bowel preparation
13
When should surgical prophylaxis be redosed based on antibiotic half-life?
2 times the half-life of the agent
14
When is prophylactic antibiotic redosing indicated beyond elapsed time?
significant intraoperative blood loss
15
When should prophylactic antibiotics end after non-cardiac surgery?
within 24 hours after non-cardiac surgery
16
When should prophylactic antibiotics end after cardiac surgery?
within 48 hours after cardiac surgery
17
What cefazolin surgical prophylaxis dose is given at weight ≥120 kg?
3 g for patients weighing ≥ 120 kg
18
What is the cefazolin redosing interval (hours)?
4
19
What is the standard surgical prophylaxis dose of clindamycin?
900 mg
20
What is the surgical prophylaxis dose of vancomycin?
15 mg/kg
21
What is the surgical prophylaxis dose of gentamicin?
5 mg/kg of ideal or adjusted body weight
22
What is the formula for adjusted body weight?
IBW + 0.4 (actual weight − IBW)
23
What is the surgical prophylaxis dose of metronidazole?
500 mg
24
What is the surgical prophylaxis dose of ceftriaxone?
2 g
25
Which agent is the recommended prophylaxis for most cardiac and vascular surgeries?
Cefazolin
26
Under CDC surveillance criteria, how long must a urinary catheter have been in place?
> 2 days
27
When must a removed catheter have been present for a CDC-defined CAUTI?
the day before the event
28
What urine culture threshold is shown for CDC-defined CAUTI?
Positive urine culture > 10^5 CFU/mL
29
How many species may grow in the CDC CAUTI urine culture?
no more than two species of organisms
30
What colony count defines asymptomatic bacteriuria in the IDSA definition?
greater than 10^5 CFU/mL
31
What colony count defines a symptomatic CAUTI by the IDSA definition?
10^3 CFU/mL or more
32
How long after catheter removal does IDSA include symptomatic CAUTI?
within the previous 48 hours
33
What is the most prevalent pathogen causing CAUTIs?
E coli
34
What is the most effective approach to CAUTI prevention?
minimize the use of urinary catheters
35
When should postoperative urinary catheters be removed if possible?
within 24 hours postoperatively
36
Which practice is NOT recommended for preventing CAUTI?
NOT recommended: Routine screening or treatment of asymptomatic bacteriuria
37
What is NOT recommended solely because a urinary catheter is placed?
NOT recommended: Use of systemic antibiotic prophylaxis solely due to catheter placement
38
What drainage-bag practice should NOT be used to prevent CAUTI?
NOT recommended: Addition of antibiotics to drainage bag
39
How many days must a central line be present for the CDC CLABSI definition?
more than 2 days
40
Which clinical findings satisfy CDC bloodstream infection symptoms with common skin flora?
temperature greater than 100.4°F [38°C], chills, hypotension
41
What cultures establish definitive catheter-related bloodstream infection by IDSA?
same organism or organisms grow from at least 1 percutaneous blood culture and from the CVC tip
42
What other paired cultures can establish catheter-related bloodstream infection?
1 from a catheter hub and 1 from a peripheral vein
43
What organisms commonly cause CLABSIs?
coagulase-negative staphylococci (e.g., S epidermidis), S aureus, Candida spp, and enteric gram-negative bacilli
44
What parenteral nutrition exposure increases Candida CLABSI risk?
total parenteral nutrition
45
Which site has lower CLABSI risk than the IJ or femoral sites?
subclavian vein
46
What skin cleanser is recommended for central-line insertion?
Alcohol-based chlorhexidine skin cleanser
47
What bathing intervention is part of CLABSI prevention?
Daily chlorhexidine baths
48
What dressing is part of essential CLABSI prevention practices?
Chlorhexidine-containing site/catheter dressings
49
Should routine systemic antibiotics be used to prevent CLABSI?
Do not use systemic antibiotic prophylaxis.
50
When can antibiotic lock therapy be considered for central lines?
patients with limited venous access or a history of catheter-related bloodstream infections
51
What CSF glucose value is a strong predictor of bacterial meningitis?
CSF glucose less than 40 mg/dL
52
What CSF-to-blood glucose ratio suggests bacterial meningitis?
less than 0.6
53
Which culture is most specific for health care-associated meningitis?
CSF culture
54
When should empiric antimicrobials be initiated for suspected bacterial meningitis?
as soon as possible after bacterial meningitis is suspected
55
Which pathogen has the clearest benefit from adjunctive dexamethasone?
Streptococcus pneumoniae
56
What is the recommended adjunctive dexamethasone dose in bacterial meningitis?
0.15 mg/kg every 6 hours for up to 96 hours
57
When is the first dexamethasone dose given in meningitis?
10–20 minutes before, or at least concomitant with, the first dose of antimicrobial therapy
58
What is recommended for an infected CSF shunt?
complete removal of an infected CSF shunt and replacement with an external ventricular drain
59
How long should external ventricular drains be clamped after intraventricular antibiotics?
15-60 minutes
60
What formulation requirement applies to intraventricular antibiotics?
preservative free
61
What CSF antibiotic concentration target is given for intraventricular therapy?
10-20 times the MIC
62
What is the minimum duration of therapy for meningitis in general?
at least 7 days
63
What meningitis duration is recommended for pneumococcus, staphylococci and gram-negative bacilli?
10–14 days
64
What meningitis duration is recommended for Listeria?
at least 21 days
65
How long should CSF be negative for S. aureus before shunt replacement?
at least 10 days
66
What empiric regimen is listed for community-acquired meningitis, age 18–50?
Vancomycin + third-generation cephalosporin
67
What is added to empiric meningitis therapy for age over 50 or predisposing condition?
ampicillin
68
What empiric regimen covers meningitis after neurosurgery?
Vancomycin + cefepime or ceftazidime or meropenem
69
What is the ampicillin dose listed for meningitis?
2 g IV q4hr
70
What is the ceftriaxone dose listed for meningitis?
2 g IV q12hr
71
What is the cefepime dose listed for meningitis?
2 g IV q8hr
72
What is the meropenem dose listed for meningitis?
2 g IV q8hr
73
What is the vancomycin intraventricular dose listed?
10–20 mg once daily
74
Why is piperacillin/tazobactam not recommended for meningitis?
low penetration of tazobactam
75
What is the goal of antibiotic stewardship?
optimize clinical outcomes while minimizing unintended consequences of antimicrobial use
76
What does antibiotic stewardship seek to improve?
selection of optimal antimicrobial drug regimen, including dosing, duration, and route of administration
77
Which two adverse outcomes are antimicrobial stewardship programs intended to minimize?
antimicrobial resistance and adverse drug reactions
78
What tracking metric is specifically cited in the TJC stewardship standards?
days of therapy per 1000 days present or 1000 patient-days
79
What two primary stewardship review strategies are recommended by TJC?
preauthorization for specific antibiotics and/or prospective review and feedback
80
What stewardship strategy involves shortening therapy and stopping unnecessary drugs?
Streamlining or de-escalation of therapy
81
Which antibiotics have IDSA-recommended PK and dose monitoring programs?
vancomycin and aminoglycosides
82
What route change is an ASP core activity?
Parenteral to oral conversion
83
What educational approach does IDSA recommend against as a standalone stewardship strategy?
didactic education alone
84
What is the back-end antimicrobial stewardship strategy?
Prospective audit with intervention and feedback
85
What is the front-end antimicrobial stewardship strategy?
Formulary restriction and preauthorization
86
What strategy involves scheduled antimicrobial substitution and is not recommended by IDSA?
Antimicrobial cycling
87
What process metrics can evaluate a stewardship program?
days of therapy, provider adherence to clinical pathway, time to effective therapy
88
What outcome metrics can evaluate a stewardship program?
LOS, mortality, 30-day readmission
89
What happens to mortality with ICU prospective audit and feedback according to meta-analyses?
no increase in mortality
90
How long can traditional pathogen identification and susceptibility testing take?
72–96 hours
91
Within what time are rapid blood-culture tests meant to offer actionable information?
the first 24 hours from the time of culture positivity
92
What common limitation affects many rapid diagnostic techniques?
inability to detect polymicrobial infections
93
What advantage can pathogen detection directly from whole blood provide?
identify bacteria in patients with recent or current antibiotic exposure
94
What molecular target does PNA FISH identify?
species-specific ribosomal RNA
95
What is the reported sensitivity and specificity of PNA FISH?
96%–100%
96
What does PNA FISH not provide?
antimicrobial sensitivity data
97
Which rapid method distinguishes S. aureus from coagulase-negative staphylococci?
PNA FISH
98
What does MALDI-TOF stand for?
Matrix-assisted laser desorption-ionization/time of flight
99
What is the sensitivity and specificity of MALDI-TOF?
98%–100%
100
What key susceptibility information does MALDI-TOF not generally provide?
no antimicrobial susceptibility is reported
101
Which gene is targeted by MRSA PCR?
mecA gene
102
What is the key stewardship use of MRSA PCR?
Earlier de-escalation of anti-MRSA antimicrobials
103
What is the reported MRSA PCR negative predictive value in the chapter?
98%
104
Which resistance genes are detected by described multiplex PCR methods?
mecA - methicillin resistance; van A/B - vancomycin resistance
105
What type of technology is the Verigene blood-culture test?
Nanoparticles (Microarray)
106
What is the range of sensitivity and specificity for Verigene testing?
93%–100%
107
What is the BioFire PCR turnaround time after a positive blood culture?
1 hr
108
Which gene indicates methicillin-resistant S. aureus in the rapid diagnostic treatment table?
mecA-positive
109
What is the preferred treatment for mecA-positive S. aureus in Table 6?
Vancomycin
110
What is the preferred treatment for mecA-negative S. aureus in Table 6?
Nafcillin
111
What is the recommended treatment for vanA/B-positive E. faecium in Table 6?
Daptomycin
112
Which drug group is recommended for CTX-M-producing Enterobacterales in Table 6?
Carbapenems (ertapenem, imipenem, meropenem)
113
Which test detects C. difficile toxin A or B genes?
Nucleic acid amplification methods
114
What is the reported sensitivity and specificity of rapid C. difficile PCR tests?
90%–96%
115
Why can repeated rapid C. difficile PCR testing be problematic?
only furthers the chance of false positivity
116
Why can blood cultures fail to detect invasive candidiasis?
negative blood cultures
117
Which three fungal pathogens can serum β-d-glucan detect?
Candida, Aspergillus, and Pneumocystis
118
What are the reported T2 Candida sensitivity and specificity?
High sensitivity (91%) and specificity (98%)
119
What biomarker is specific to Candida spp.?
Mannan
120
Which fungal pathogen produces galactomannan?
Aspergillus spp.
121
What does procalcitonin reflect?
host response to bacterial infections
122
How quickly is PCT released after exposure to bacterial toxins?
within 2–4 hours
123
What is the plasma half-life of PCT?
24 hours
124
What is the usual PCT concentration in healthy patients?
less than 0.05 mcg/L
125
Which chronic condition may raise baseline PCT?
Chronic kidney disease
126
Should low PCT be used alone to withhold antibiotics in suspected sepsis?
the recommendation to withhold antimicrobials when the PCT was low
127
How should low or falling PCT be used during treatment?
shorten the duration of antimicrobial therapy
128
How does PCT guidance affect antibiotic duration in the cited largest trial?
median 5 days vs. 7 days
129
What PCT reduction by day 4 was associated with prognostic information?
at least 80% by day 4
130
Which PCT value suggests antibiotic cessation in the sample algorithm?
PCT < 0.25 mcg/L
131
What PCT fall from peak supports stopping antibiotics in the sample algorithm?
Decrease by ≥ 80%
132
What PCT level with inadequate decline supports continuing antibiotics?
PCT ≥ 0.5 mcg/L
133
What score range on the host response diagnostic is interpreted as viral infection?
0–34 = viral infection
134
What score range on the host response diagnostic is interpreted as bacterial infection?
66–100 = bacterial infection
135
Which organization determines MIC breakpoint standards?
Clinical & Laboratory Standards Institute (CLSI)
136
What is the qualitative output of Kirby-Bauer disk diffusion?
sensitive, intermediate, or resistant
137
How is inhibition-zone diameter related to MIC in disk diffusion?
inversely proportional to the MIC value
138
Which susceptibility method uses serial twofold antibiotic dilutions?
Dilution methods
139
What susceptibility method uses a calibrated plastic strip?
E-test
140
How is an MIC identified using an E-test strip?
intersection between the zone of inhibition and the edge of the calibrated strip
141
Which test detects inducible clindamycin resistance?
double-disk diffusion
142
Can routine AST detect inducible macrolide-lincosamide-streptogramin resistance?
not detected by routine AST
143
Which antibiotic inhibitor confirms ESBL activity in confirmatory testing?
clavulanic acid
144
What MIC decrease after clavulanic acid confirms ESBL activity?
three 2-fold dilution decreases
145
What is the updated ceftriaxone susceptibility cutoff for Enterobacterales in Table 7?
≤ 1
146
What is the updated cefazolin susceptibility cutoff for non-UTI infections in Table 7?
≤ 2
147
What agent used in confirmatory testing inhibits zinc-mediated MBL?
ethylene-diamine tetraacetic acid
148
What KPC screening clue is especially sensitive on AST?
Ertapenem resistance
149
What carbapenem MIC in an Enterobacterales should prompt KPC evaluation?
1 mcg/mL or greater
150
What mismatch can lead labs to report susceptible results despite current CLSI resistance criteria?
FDA labeling may not be up to date with the current CLSI recommendations
151
What administration strategy can optimize beta-lactam PK/PD when MIC is high?
extended- or continuous-infusion β-lactams
152
What other options may optimize therapy when MICs are challenging?
using a higher dose
153
Which Enterobacterales resistance is an urgent CDC threat?
Carbapenem-resistant Enterobacterales
154
Which fungal pathogen is also a CDC urgent resistance threat?
Candida auris
155
Which staphylococcal pathogen is listed as a serious resistance threat?
MRSA
156
What mechanisms produce beta-lactam resistance in Table 9?
β-Lactamases (AmpC, ESBL, KPC)
157
What resistance mechanism affects fluoroquinolone target proteins?
Altered DNA gyrase and topoisomerase
158
What enzyme alteration is associated with trimethoprim resistance?
Altered dihydrofolate reductase
159
Which resistance mechanism reduces antibiotic entry into bacteria?
Decreased permeability
160
What is another bacterial resistance mechanism involving pumps?
Increased efflux
161
What resistance mechanism includes altered penicillin binding proteins?
Target modification
162
What bacterial resistance mechanism involves beta-lactamases?
Hydrolysis
163
What is colonization pressure?
Proportions of people colonized with resistant bacteria
164
What drugs are hydrolyzed by ESBL-producing pathogens?
third-generation cephalosporins and aztreonam
165
Which species most commonly produce ESBLs in the chapter?
E. coli and K. pneumoniae spp.
166
What is the preferred treatment class for severe ESBL infections?
Carbapenems
167
What trial mortality comparison is provided for PTZ versus meropenem in ceftriaxone-resistant bloodstream infection?
12.3% vs. 3.7%
168
What does the ESBL evidence suggest about piperacillin-tazobactam?
do not support the use of piperacillin/tazobactam
169
What cefepime MIC is noted as a possible consolidation-therapy option in stable ESBL infection?
1 mcg/mL or less
170
What cefepime MIC range represents susceptible dose-dependent for Enterobacterales?
4 and 8 mcg/mL
171
For which infection did cefepime-enmetazobactam receive FDA approval?
complicated UTIs including pyelonephritis
172
Which carbapenemases are NOT covered by cefepime-enmetazobactam?
KPC, metallo-β-lactamases, or some oxacillinases
173
What antibiotics do AmpC enzymes confer resistance to?
penicillins and narrow-spectrum cephalosporins
174
Do tazobactam and clavulanate add coverage against AmpC?
tazobactam and clavulanic acid would not provide additional coverage
175
What bacterial species are associated with AmpC inducibility?
Enterobacter, Citrobacter, Serratia, Morganella, Providencia, and Pseudomonas
176
What happens when AmpC is derepressed?
resistance to third-generation cephalosporins and broad-spectrum penicillins
177
Which cephalosporin generally retains activity against AmpC derepressed mutants?
Cefepime
178
What two options are listed for severe AmpC infections?
Carbapenem and cefepime
179
Which bacterial groups can express carbapenemase?
Acinetobacter, Pseudomonas, and Enterobacterales
180
Which glycylcycline inhibits the 30S ribosomal subunit?
Tigecycline
181
Which important gram-negative pathogens are not covered by tigecycline?
Pseudomonas, Providencia, Proteus, or Morganella
182
Why is tigecycline generally avoided for UTIs?
Urinary elimination is 8%–11%
183
What PK property raises concerns about tigecycline for bacteremia?
Wide volume of distribution: 7–10 L/kg
184
Which infection had lower tigecycline treatment success compared with imipenem?
hospital-acquired pneumonia
185
What FDA safety warning was issued for tigecycline?
possible increased mortality risk
186
What pathogens do polymyxins NOT cover?
Proteus, Providencia, Burkholderia, Serratia, or Stenotrophomonas
187
What is the prodrug administered in colistin preparations?
colistimethate
188
Which active compound results from hydrolysis of colistimethate?
colistin
189
What is the PK/PD index of colistin activity?
area under the curve/MIC ratio
190
How many colistin IU correspond to ~100 mg colistin-based activity?
3 million IU
191
What is the international consensus colistin loading dose?
300 mg colistin base activity loading dose
192
What is the international consensus colistin maintenance dose?
300-360 mg colistin base activity divided every 12 hours
193
What is the international consensus polymyxin B loading dose?
2–2.5 mg/kg total body weight
194
What is the international consensus polymyxin B maintenance dose?
1.25–1.5 mg/kg total body weight every 12 hours
195
Which polymyxin is preferred for routine systemic use?
Polymyxin B
196
Which polymyxin is preferred for UTIs?
Colistin
197
What is the primary dose-limiting adverse effect of polymyxins?
Nephrotoxicity
198
Which KPC-producing organisms are treated with ceftazidime/avibactam?
KPC-producing Enterobacterales
199
Which resistance enzyme group is not meaningfully inhibited by ceftazidime-avibactam?
metallo-β-lactamase-expressing strains
200
What carbapenemase class does vaborbactam inhibit?
class A carbapenemases, including KPC
201
Does meropenem/vaborbactam expand coverage against carbapenem-resistant Pseudomonas?
It is not found to expand coverage to carbapenem-resistant Acinetobacter baumannii, Pseudomonas aeruginosa, or Stenotrophomonas maltophilia.
202
Which enzyme does cilastatin inhibit?
dehydropeptidase-1
203
Which resistant organisms are targeted clinically by imipenem-relebactam?
KPC-producing Enterobacterales
204
What is cefiderocol's bacterial uptake mechanism?
bacterial iron transport systems
205
What common phrase describes cefiderocol's mechanism?
“Trojan Horse” strategy
206
Which gram-negative organisms does cefiderocol cover?
Enterobacterales, Pseudomonas, Acinetobacter, and Stenotrophomonas
207
Does cefiderocol have meaningful gram-positive activity?
no clinically relevant in vitro activity
208
Which beta-lactamase groups can cefiderocol resist?
serine (including KPCs and OXA-48) and metallo-β-lactamases
209
Which antibiotic combination was specifically developed for CRAB?
Sulbactam/durlobactam
210
Which component of sulbactam/durlobactam has intrinsic Acinetobacter activity?
Sulbactam
211
What drug is highlighted for difficult-to-treat multidrug-resistant Pseudomonas?
Ceftolozane/tazobactam
212
What higher ceftolozane/tazobactam dose was evaluated for hospital-acquired/VAP?
3 g every 8 hours
213
Which aminoglycoside dose is recommended for expanded Pseudomonas coverage?
tobramycin 7 mg/kg every 24 hours
214
Which aminoglycoside is no longer recommended for Pseudomonas?
Gentamicin
215
Which two treatments are discussed for MRSA bacteremia?
vancomycin or daptomycin
216
What daptomycin dose was used in the right-sided endocarditis study?
6 mg/kg
217
What higher daptomycin doses do some experts use?
8–10 mg/kg
218
What treatments are options for community-acquired MRSA pneumonia?
vancomycin or linezolid
219
What is the AUC monitoring guideline target for vancomycin?
AUC
220
What is the role of tedizolid in critical care?
Place in therapy among critically ill patients is limited
221
What vancomycin AUC24 target is recommended for serious MRSA infection?
400–600 mg/hour/L
222
Are trough-only targets still recommended for serious MRSA infection?
Trough targets are no longer recommended
223
What method is recommended for vancomycin dose adjustments?
Bayesian dosing
224
What is the oral/IV daily dose of tedizolid?
200 mg once daily
225
What drug class is tedizolid?
Oxazolidinone
226
Which PVL-associated clinical syndrome is linked to community-acquired MRSA?
necrotizing pneumonia
227
What single oral temperature defines fever in febrile neutropenia?
101°F (38.3°C) or greater
228
What sustained oral temperature defines fever in neutropenia?
100.4°F (38.0°C) or greater orally for more than 1 hour
229
What ANC defines neutropenia in this chapter?
Less than 500 neutrophils/mm3
230
What MASCC score signals low-risk febrile neutropenia?
21 or greater
231
What MASCC score signals high-risk febrile neutropenia?
less than 21
232
What ANC level is a high-risk criterion for febrile neutropenia?
less than 100 neutrophils/mm3
233
What expected duration of neutropenia signals high risk?
longer than 7 days
234
What initial antibiotic regimen is recommended in high-risk febrile neutropenia?
monotherapy with an intravenous antipseudomonal β-lactam
235
What initial options are listed for febrile neutropenia with type I beta-lactam hypersensitivity?
ciprofloxacin or aztreonam plus vancomycin
236
When should dual gram-negative coverage be considered in neutropenic fever?
patients with shock or if antimicrobial resistance is suspected
237
When is empiric vancomycin indicated in febrile neutropenia?
shock, suspected catheter-related infection, skin and soft tissue infection, pneumonia, and/or hemodynamic instability
238
When can empiric gram-positive coverage be stopped if no infection is found?
48–72 hours
239
When should empiric antifungal therapy be considered in persistent neutropenia?
4–7 days after initiation of antibacterial agents
240
What ANC indicates recovery before stopping treatment for febrile neutropenia?
ANC greater than 500 cells/mm3
241
How long must patients be afebrile before treatment cessation?
at least 48 hours
242
Should hematopoietic growth factors routinely be used to treat febrile neutropenia?
should not be used for the treatment of febrile neutropenia
243
At what anticipated febrile neutropenia risk should growth-factor prophylaxis be considered?
20% or greater
244
When are most infections seen after solid organ transplant?
first 6 months after transplantation
245
Why are opportunistic infections uncommon in the first posttransplant month?
full effects of immunosuppression are not yet present
246
What usually causes viral/fungal infection in the first posttransplant month?
donor derived
247
Who should be consulted if severe infection requires reduced immunosuppression?
transplant team
248
What can cause low CD4 counts in patients without HIV?
Critical illness
249
What is immune reconstitution inflammatory syndrome (IRIS)?
Unexpected worsening of existing OI or unmasking of previously unrecognized illness
250
What HIV treatment change is linked to IRIS?
recent HAART initiation
251
What risk factor for IRIS is related to baseline viral burden?
High baseline HIV viral load
252
What treatment is suggested for severe IRIS requiring vasopressors or ventilation?
prednisone
253
If one antiretroviral must be interrupted, what is generally recommended?
all of the therapies should be discontinued
254
Why can simultaneous NNRTI discontinuation cause resistance?
a period of functional NNRTI monotherapy
255
What NRTI complication is associated with mitochondrial toxicity?
lactic acidosis
256
Which older NRTIs are associated with lactic acidosis?
zidovudine, stavudine, and didanosine
257
What pharmacogenomic allele predicts abacavir hypersensitivity?
HLA-B*5701
258
What must never be done after abacavir hypersensitivity?
rechallenge contraindicated
259
What serious adverse effect is associated with raltegravir?
rhabdomyolysis
260
What important serious toxicities are associated with tipranavir?
hepatotoxicity and intracranial hemorrhage
261
When is P. jirovecii prophylaxis indicated by CD4 count?
< 200 cells/mm3
262
What CD4 percentage threshold is listed for PJP prophylaxis?
< 14%
263
What is the preferred PJP prophylaxis regimen?
TMP/SMX 1 DS PO daily
264
What is the TMP-SMX treatment dose and duration for PJP?
15–20 mg/kg PO/IV divided q6–8hr x 21 days
265
At what PaO2 is adjunctive PJP prednisone indicated?
Pao2 < 70 mm Hg
266
At what A–a gradient is adjunctive PJP prednisone indicated?
alveolar-arterial O2 gradient > 35
267
What is the initial prednisone dose for moderate/severe PJP?
prednisone 40 mg PO q12hr x 5 days
268
What is the prednisone dose on days 6–10 for PJP?
40 mg/day x 5 days
269
What is the prednisone dose on days 11–21 for PJP?
20 mg/day x 11 days
270
What methylprednisolone conversion is used in PJP?
75% of the corresponding oral prednisone dose
271
Which HIV patients need toxoplasmosis prophylaxis?
< 100 cells/mm3 and Toxoplasma IgG positive
272
What is the preferred toxoplasmosis prophylaxis?
TMP/SMX 1 DS PO daily
273
What is the preferred toxoplasmosis treatment combination?
Pyrimethamine + sulfadiazine + leucovorin
274
How long is toxoplasmosis induction therapy given?
6 wk
275
What CD4 count is associated with MAC prophylaxis consideration?
< 50 cells/mm3
276
When may MAC prophylaxis be needed at CD4 <50?
not receiving antiretroviral therapy (ART)
277
What is the preferred MAC prophylaxis dose of azithromycin?
Azithromycin 1200 mg once weekly
278
What is the core treatment combination for MAC?
Clarithromycin or azithromycin plus ethambutol
279
What is preferred for cryptococcal meningitis induction?
Liposomal amphotericin IV 3-4 mg/kg/day + flucytosine
280
How long is cryptococcal meningitis induction treatment?
2 wk
281
What is cryptococcal meningitis consolidation treatment?
Fluconazole PO/IV 400 mg/day
282
How long is cryptococcal meningitis consolidation?
8 wk
283
What is cryptococcal meningitis maintenance dose?
Fluconazole PO/IV 200 mg/day
284
How long is cryptococcal meningitis maintenance therapy?
1 yr
285
What is an option for CMV induction treatment?
Ganciclovir 5 mg/kg q12hr for 14–21 days
286
What is the oral induction regimen for CMV?
Valganciclovir PO 900 mg BID for 14–21 days
287
What is an alternative drug for treatment of resistant CMV?
Foscarnet
288
What drug is coadministered with cidofovir to limit toxicity?
probenecid
289
What interaction occurs between rilpivirine and proton-pump inhibitors?
Contraindicated with proton pump inhibitors
290
What is the interaction of ritonavir-boosted protease inhibitors with rivaroxaban?
Do not coadminister
291
What is the apixaban recommendation with boosted protease inhibitors at 2.5 mg BID?
Do not administer in patients who require 2.5 mg BID
292
What is the mechanism of action of amphotericin B?
Binds to ergosterol in the fungal cell membrane
293
Which Candida species is excluded from amphotericin's usual spectrum?
C. lusitaniae
294
What is the conventional amphotericin B dose?
0.5–1.0 mg/kg/day
295
What is the lipid amphotericin B dose?
3–5 mg/kg/day
296
Which electrolytes may be wasted with amphotericin B?
Potassium, magnesium, phosphate
297
What saline loading approach is listed to limit amphotericin nephrotoxicity?
500 mL of normal saline before and after infusion of amphotericin
298
What premedication timing is listed for amphotericin infusion reactions?
30–60 minutes before infusion
299
Which medication may be used for amphotericin-associated rigors?
Meperidine 25–50 mg intravenously
300
What is the mechanism of action of triazole antifungals?
blocking the CYP enzyme 14-α-sterol-demethylase

128 more cards in OutLearn. Open the full deck

Study all 428 cards for free

More Medicine & health flashcards

Chapter 1 Pharm24 cardsMedicine & health · EnglishMadiruth2Ocular Drug Delivery19 cardsMedicine & health · EnglishBarzoInfluenza14 cardsMedicine & health · EnglishcaeChikiting Ligtas Immunization Campaign10 cardsMedicine & health · EnglishALICECLS Exam 4: Strongyloides stercoralis194 cardsMedicine & health · EnglishJESSQTRANRespiratory Diseases131 cardsMedicine & health · EnglishvstanisNURS180 Week One: Pancreas and Glucose Regulation92 cardsMedicine & health · EnglishTaylorNeurology: Fainting, Seizures and Epilepsy72 cardsMedicine & health · EnglishTejuhistology introduction.57 cardsMedicine & health · EnglishAnthonyVeterinary Hematology: Leukocytosis and Stress Leukograms47 cardsMedicine & health · EnglishDanielaN1165 decks · 223 cardsMedicine & healthkylamDOSAGE FORMS5 decks · 149 cardsMedicine & healthLlance

All Medicine & health decks

Study these decks in the app

Free on iPhone, Android, Mac and the web. Add any deck to your account in one tap.

Download on the App StoreGet it on Google Play
Study all 428 cards for free